Clinical Trial Update: Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of cilostazol and probucol on atherosclerosis-related biomarkers in Type 2 Diabetes Mellitus and Arteriosclerosis Obliteran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis Obliterans
• Type 2 Diabetes Mellitus

Drugs mentioned

• Probucol (Probucol)
• cilostazol (Pletal) (cilostazol)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans | Phase 4 | Status: COMPLETED